Appili Therapeutics Net Income Applicable To Common Shares Over Time
| APLI Stock | CAD 0.02 0.01 33.33% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Appili Therapeutics Performance and Appili Therapeutics Correlation. Appili |
Cross Equities Net Income Applicable To Common Shares Analysis
Compare Appili Therapeutics and related stocks such as XORTX Therapeutics, Aptose Biosciences, and Kane Biotech Net Income Applicable To Common Shares Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XRTX | (474.2 K) | (474.2 K) | (474.2 K) | (474.2 K) | (474.2 K) | (474.2 K) | (474.2 K) | (474.2 K) | (3.8 M) | (629.6 K) | (1.3 M) | (1.7 M) | (9.5 M) | (9.5 M) | (9.5 M) | (8.5 M) | (8.1 M) |
| APS | (10.6 M) | (10.6 M) | (10.6 M) | (10.6 M) | (13.3 M) | (11.7 M) | (14.2 M) | (11.6 M) | (28.9 M) | (26.3 M) | (55.2 M) | (65.4 M) | (41.8 M) | (41.8 M) | (41.8 M) | (37.6 M) | (39.5 M) |
| KNE | (1.4 M) | (1.4 M) | (1.4 M) | (1.4 M) | (1.6 M) | (1.7 M) | (2.5 M) | (3.4 M) | (3.3 M) | (960.2 K) | (3.7 M) | (4.6 M) | (3.9 M) | (3.9 M) | (3.9 M) | (3.5 M) | (3.7 M) |
| THRM | (356.4 K) | (356.4 K) | (356.4 K) | (356.4 K) | (356.4 K) | (206 K) | (965.6 K) | (1.2 M) | (421.9 K) | (626.7 K) | (8.6 M) | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (5.3 M) | (5 M) |
| LFST | (33.3 M) | (33.3 M) | (33.3 M) | (33.3 M) | (33.3 M) | (33.3 M) | (33.3 M) | (33.3 M) | (63.2 M) | (26.2 M) | (23.8 M) | (23.8 M) | (23.8 M) | (23.8 M) | (23.8 M) | (27.4 M) | (28.7 M) |
Appili Therapeutics and related stocks such as XORTX Therapeutics, Aptose Biosciences, and Kane Biotech Net Income Applicable To Common Shares description
The net income that remains after preferred dividends have been deducted, available to common shareholders.My Equities
My Current Equities and Potential Positions
| Appili Therapeutics | APLI |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 1344 Summer Street, |
| Exchange | Toronto Exchange |
CAD 0.02
Other Information on Investing in Appili Stock
Appili Therapeutics financial ratios help investors to determine whether Appili Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Appili with respect to the benefits of owning Appili Therapeutics security.